Charles H. Hennekens, MD | Psychiatrist.com

Original Research

Comorbid Somatic Illnesses in Patients With Severe Mental Disorders: Clinical, Policy, and Research Challenges

March 18, 2008

W. Wolfgang Fleischhacker, Marcelo Cetkovich-Bakmas, Marc De Hert, et al

Educational Activity

Series Introduction and Cardiovascular Disease in Patients With Schizophrenia

May 15, 2007

Charles H. Hennekens, John W. Newcomer

Article

Increasing Global Burden of Cardiovascular Disease in General Populations and Patients With Schizophrenia

April 16, 2007

Charles H. Hennekens

Article

Antipsychotic Drugs, Insulin Resistance, Hyperglycemia, and Diabetes Mellitus

May 1, 2004

Daniel E. Casey, Dan W. Haupt, John W. Newcomer, et al

Article

Conclusions: Antipsychotic-Induced Weight Gain and Metabolic Abnormalities

May 1, 2004

Daniel E. Casey, Dan W. Haupt, John W. Newcomer, et al

Article

Epidemiology of Cardiovascular Disease and Major Metabolic Risk Factors

May 1, 2004

Daniel E. Casey, Dan W. Haupt, John W. Newcomer, et al

Article

The Impact of Atypical Antipsychotics on Weight Gain

May 1, 2004

Daniel E. Casey, Dan W. Haupt, John W. Newcomer, et al

Article

Monitoring Metabolic Side Effects

May 1, 2004

Daniel E. Casey, Dan W. Haupt, John W. Newcomer, et al

Article

Schizophrenia, Metabolic Disorders, and Cardiovascular Disease

May 1, 2004

Daniel E. Casey, Dan W. Haupt, John W. Newcomer, et al

Article

Treatment Recommendations for Psychiatrists

May 1, 2004

Daniel E. Casey, Dan W. Haupt, John W. Newcomer, et al